{"product_id":"olverembatinib","title":"Olverembatinib","description":"\u003cp\u003e\u003cspan data-huuid=\"369110413223074742\"\u003eOlverembatinib is a small-molecule, oral BCR-ABL1 TKI that works by inhibiting the BCR-ABL1 kinase at the ATP binding site. \u003c\/span\u003e\u003cspan data-huuid=\"369110413223072535\"\u003eIt's designed to be effective against both wild-type and mutant BCR-ABL1.\u003c\/span\u003e\u003c\/p\u003e\u003cul\u003e\u003cli\u003e\n\u003cspan data-huuid=\"5813577302449632437\"\u003eOlverembatinib \u003c\/span\u003esold under the brand name 耐立克® in china.\u003c\/li\u003e\u003c\/ul\u003e\u003cp\u003eIn 2021, it was approved in China \"for the treatment of adult patients with TKI-resistant chronic-phase CML (CML-CP) or accelerated-phase CML (CML-AP) harbouring the T315I mutation\"\u003c\/p\u003e","brand":"Ascentage Pharma, China","offers":[{"title":"Default Title","offer_id":44797956948011,"sku":"RL3220250101","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2025-01-133.png?v=1787022273","url":"https:\/\/xomeds.com\/products\/olverembatinib","provider":"XOMEDS","version":"1.0","type":"link"}